Onderneming AIT Therapeutics Inc Other OTC
Aandelen
US50027L1070
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
||
- USD | - |
30/04 | BEYOND AIR, INC. : Een koopadvies van Truist Securities | ZM |
12/02 | Beyond Air, Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023 | CI |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 13-01-17 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 01-09-21 |
Amir Avniel
PSD | President | 50 | 13-01-17 |
Andrew Colin
CTO | Chief Tech/Sci/R&D Officer | - | 01-12-21 |
Chief Tech/Sci/R&D Officer | - | - | |
Jeff Myers
CTO | Chief Tech/Sci/R&D Officer | - | 27-03-23 |
Michael Gaul
COO | Chief Operating Officer | 70 | 01-05-20 |
Edward Barger
IRC | Investor Relations Contact | - | 01-10-22 |
Kori-Ann Taylor
SAM | Sales & Marketing | - | 20-05-21 |
Peter Senior
PRN | Corporate Officer/Principal | - | 03-05-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 01-08-15 |
William Forbes
BRD | Director/Board Member | 62 | 13-08-18 |
Erick Lucera
BRD | Director/Board Member | 57 | 10-08-17 |
Steven Lisi
CEO | Chief Executive Officer | 53 | 13-01-17 |
Amir Avniel
PSD | President | 50 | 13-01-17 |
Robert Carey
BRD | Director/Board Member | 65 | 13-02-19 |
Yoori Lee
BRD | Director/Board Member | 51 | 02-01-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 45 898 321 | 37 646 892 ( 82,02 %) | 0 | 82,02 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,56% | 181 mld. | |
-0,11% | 108 mld. | |
-6,17% | 66,12 mld. | |
+2,64% | 50,65 mld. | |
+6,58% | 43,11 mld. | |
+3,55% | 40,74 mld. | |
+21,98% | 31,6 mld. | |
+16,53% | 25,56 mld. | |
-5,81% | 24,16 mld. |
- Beurs
- Aandelen
- Koers XAIR
- Koers
- Onderneming AIT Therapeutics Inc